1. From the Department of Medicine, Institute of Molecular Cardiology (Q.O., R.R.E.A., X.-L.T., K.B., S.P.J., R.B., T.M.A.M.), University of Louisville, KY
2. Tenaya Therapeutics, South San Francisco, CA (Z.J., K.N.I.)
3. Departments of Anatomical Sciences and Neurobiology (S.M.H., A.K.), University of Louisville, KY
4. Department of Bioengineering (G.G., A.E.-B.), University of Louisville, KY
5. Envirome Institute, Diabetes and Obesity Center, Department of Medicine (B.R., B.G.H., S.P.J., T.M.A.M.), University of Louisville, KY
6. Division of Cardiology and Consortium for Fibrosis Research & Translation, Department of Medicine, University of Colorado, Aurora (Y.-H.L., T.A.M.)
7. National Heart & Lung Institute, Imperial College London, United Kingdom (S.A.W., F.P., C.M.T.)
8. Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Germany (F.P.)
9. Department of Pharmacology and Toxicology (T.M.A.M.), University of Louisville, KY
10. Institute of Cardiovascular Sciences, University of Manchester, United Kingdom (T.M.A.M.)
11. Faculty of Pharmacy, Zagazig University, Egypt (T.M.A.M.).